Sivers Semiconductors: Restated Losses and an Insider Probe Overshadow a Promising Q1 Catalyst

Swedish chipmaker Sivers faces a critical test on May 29 as Q1 results and MSCI inclusion collide with accounting restatements, an insider trading probe, a board overhaul, and a 13x valuation gap between price and analyst target.

A single day next week will test whether the market's enthusiasm for Sivers Semiconductors is built on substance or speculation. On May 29, the Swedish photonics and mmWave specialist releases its first-quarter numbers under a new accounting framework — and is simultaneously inducted into the MSCI Sweden Small-Cap Index. But the dual event arrives amid a storm of complications that includes a restated set of books, an insider-trading investigation, a major shareholder in distress, and a boardroom makeover.

The company's financials have taken a harder hit than previously reported. After shifting to US PCAOB audit standards, Sivers cut its 2024 revenue to 219.2 million Swedish kronor from the original 243.7 million, while the net loss widened to 183.9 million kronor from 116.3 million. The 2025 figures underwent similar surgery: revenue edged up to 306.6 million kronor, but the net loss ballooned to 222.6 million kronor from the earlier 186.5 million. The swings were blamed on deferred revenue recognition, corrected inventory valuations, and write-downs on capitalised development costs. The operating loss (EBIT) for last year came in at 177.8 million kronor.

The board is being reshaped with Nasdaq ambitions in mind. Founder Erik Fällström, Keith Halsey, and former deputy chairman Tomas Duffy are leaving, while two new candidates — Joakim Nideborn, a former CFO of listed tech companies, and Helena Svancar, with over two decades of international leadership — are proposed for election at the June 15 annual general meeting. The shift away from Scandinavian founders towards a more international profile is aimed squarely at attracting US institutional investors.

That Nasdaq listing is also under a cloud. Sweden's Economic Crime Authority is probing possible insider trading around the April announcement of the dual-listing plans. Investigator Jonas Myrdal is examining whether the EU Market Abuse Regulation was breached after an anonymous X account with significant reach posted details of the listing roughly 48 hours before the official press release. The subsequent price action was suspicious enough to trigger a formal inquiry. A confirmed violation could bring US regulators into the picture at the worst possible moment.

Meanwhile, Sivers' largest shareholder is in its own crisis. Achilles Capital's parent, DDM Finance, has filed for restructuring after bonds worth around 225 million euros came due. Its recovery plan involves selling credit and tech holdings worth between 30 million and 80 million euros — but whether the Sivers stake is on the block remains unclear. An uncontrolled sale of that position would add heavy downward pressure on the stock.

The valuation gap between the market and analysts borders on the absurd. At the current price of around 85.55 SEK, the price-to-sales multiple sits at nearly 60, while the average analyst target stands at just 6.55 SEK — a 13-fold divergence. Short sellers have taken note: Voleon Capital holds a short position of 1.86% and Two Sigma sits at 1.78%. The company itself recently raised 125 million kronor by placing 8.62 million new shares at 14.50 SEK apiece, a massive discount to the prevailing market rate that raises questions about management's internal valuation.

Operationally, the picture is more encouraging. The order pipeline has expanded 64% to $453 million, and a $6.6 million contract extension from the US Department of Defense under the CHIPS Act's EW-STAR program provides geopolitical tailwind. Management is targeting annualised revenue of $50 million to $55 million and a gross margin above 50% — the threshold for operating breakeven.

All eyes now turn to the quarterly report on May 29, the first under the revised accounting standards. It lands on the same evening the stock is added to the MSCI Sweden Small-Cap Index, a passive rebalancing that could provide near-term support. Six days later, shareholders will decide whether to endorse the new board and a long-term incentive plan that would dilute existing holders by roughly 2% through up to seven million stock options. For a stock trading at 85 SEK against a 6.55 SEK target, the May 29 numbers won't just be a routine check-in — they'll be a reality test.